Dimethylacetamide → 6-(1-(4-chlorobenzyl)-1H-pyrazol-4-ylamino)-N-(thiazol-2-yl)pyridine-3-sulfonamide
Reaction equation
[S:1]1[CH:5]=[CH:4][N:3]=[C:2]1[NH:6][S:7]([C:10]1[CH:11]=[N:12][C:13](Cl)=[CH:14][CH:15]=1)(=[O:9])=[O:8].CC1(C)C2C=CC=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=2OC2C1=CC=CC=2P(C1C=CC=CC=1)C1C=CC=CC=1.Cl.Cl.[Cl:61][C:62]1[CH:74]=[CH:73][C:65]([CH2:66][N:67]2[CH:71]=[C:70]([NH2:72])[CH:69]=[N:68]2)=[CH:64][CH:63]=1.CN(C)C(=O)C.CC(C)([O-])C.[Na+]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[Cl:61][C:62]1[CH:74]=[CH:73][C:65]([CH2:66][N:67]2[CH:71]=[C:70]([NH:72][C:13]3[N:12]=[CH:11][C:10]([S:7]([NH:6][C:2]4[S:1][CH:5]=[CH:4][N:3]=4)(=[O:9])=[O:8])=[CH:15][CH:14]=3)[CH:69]=[N:68]2)=[CH:64][CH:63]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 120 °C
Procedure
Into a Vial was added the 6-Chloro-pyridine-3-sulfonic thiazol-2-ylamide (82 mg, 0.00030 mol), 9,9-DIMETHYL-4,5-BIS(DIPHENYLPHOSPHINO)XANTHENE (21 mg, 0.000036 mol), Tris(dibenzylideneacetone)dipalladium(0) (11 mg, 0.000012 mol), [B] 1-(4-chlorobenzyl)-1H-pyrazol-4-amine dihydrochloride (1.0E2 mg, 0.00036 mol) and N,N-Dimethylacetamide (4.0 mL, 0.043 mol). The mixture was sparged with argon for ˜5 min. Sodium tert-butoxide (140 mg, 0.0015 mol) was added and the reaction mixture was heated at 120° C. for 30 min in microwave. The reaction mixture was filtered through celite. The filtrate was diluted with Ethyl acetate and washed with 0.1 N HCl solution. The aqueous phase was neutralized with 1.0 N NaOH solution, extracted with Ethyl acetate. The combined organic phase was washed with water (3×) and brine, dried over Na2SO4, filtered and was concentrated to give the crude product that was purified on Gilson (Prep LC, reverse phase, Phenomenex 250×30 mm, 15 micron C18 column, 40 mL/min. Gradient, 85% A to 100% B over 25 min. Solvent A: 7800 water/200 acetonitrile/8 TFA. Solvent B: 7200 acetonitrile/800 water/8). Fractions were checked by LC/MS and combined accordingly. LC/MS showed the product was only ˜90% pure. The combined product solution was concentrated to remove the acetonitrile, neutralized with 1.0 N NaOH solution and then extracted with Ethyl acetate (3×). The combined organic layers were dried over sodium sulfate, filtered and was concentrated to give the product as free base, which was purified again on ISCO (0% to 100% Ethyl acetate in DCM). 48 mg of the product was obtained as a pale yellow solid.
Workup
- customThe mixture was sparged with argon for ˜5 min
- filtrationThe reaction mixture was filtered through celite
- additionThe filtrate was diluted with Ethyl acetate
- washwashed with 0.1 N HCl solution
- extractionextracted with Ethyl acetate
- washThe combined organic phase was washed with water (3×) and brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationwas concentrated
- customto give the crude product that
- customwas purified on Gilson (Prep LC, reverse phase, Phenomenex 250×30 mm, 15 micron C18 column, 40 mL/min. Gradient, 85% A to 100% B over 25 min. Solvent A: 7800 water/200 acetonitrile/8 TFA. Solvent B: 7200 acetonitrile/800 water/8)
- concentrationThe combined product solution was concentrated
- customto remove the acetonitrile
- extractionextracted with Ethyl acetate (3×)
- dry with materialThe combined organic layers were dried over sodium sulfate
- filtrationfiltered
- concentrationwas concentrated
- customto give the product as free base, which
- customwas purified again on ISCO (0% to 100% Ethyl acetate in DCM)
Sources & evidence
- ORD record
- ord-a5d308aa9c2f4eb8b47fb58d7b1b7178
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08124610B2
Reaction notes
Loading…